comprehensive -WSS

comprehensive

author：focus 2025-09-29 19:05:46 - browse：11

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： White House drug shortages task force keeps mum with Congress

knowledge

hotspot

WSS

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Flu, Covid vaccination rates decline, new survey data show

The history of OxyContin, told through Purdue Pharma documents

Medicare innovation center doesn’t save money, experts say

CRISPR base editing slashes cholesterol levels in monkeys

Maui funeral service workers on devastation of fires: 'I'm in shock'

focus

comprehensive

explore

Duchenne breakthrough therapy leaves behind pioneering families

Maui funeral service workers on devastation of fires: 'I'm in shock'

Peter Hotez and the public health issue of online harassment

Some of the ways extreme heat will change life as we know it

ChatGPT in medicine: STAT answers readers' burning questions

Will an HIV vaccine ever be a reality?

Activists slam private health insurers over coverage restrictions

With Roe v Wade overturned, abortion providers work to adapt

BioMarin wins approval for gene therapy to treat hemophilia A

Who are the detained American citizens released from prison in Iran?

hotspot

Genentech weighs delaying cancer therapy after drug pricing law

Large hospital system sues Multiplan for low

CDC overhauls leadership of center that led response to Covid

Maui funeral service workers on devastation of fires: 'I'm in shock'

Congress extends some pandemic preparedness programs

Genentech weighs delaying cancer therapy after drug pricing law

knowledge

knowledge

hotspot

focus